bonyf NV Stock

MLBON

BE6333353298

Market Closed - Euronext Paris 11:55:00 2026-09-04 EDT			5-day change	1st Jan Change
2.480 ^EUR	0.00%		0.00%	-49.39%

02-25	Paris-listed bonyf Withdraws Nasdaq Listing Plans, In Talks for China Partnerships	MT
25-10-15	Bonyf NV Receives the EU-MDR Certification Class IIa for PerioCream	CI

News in other languages : bonyf NV

06-29	Bonyf : Annual Results 2025
01-27	Bonyf : Une année de certification, d'innovation et d'accélération commerciale
12-22	Bonyf : Mise à jour de la société sur la dynamique des marchés et les fondamentaux commerciaux
11-24	Bonyf : PerioCream devient l'innovation bonyf la plus demandée
23-02-24	Bonyf NV: Suspension du titre

More news

Managers and Directors : bonyf NV

Manager	Title	Age	Since
Jean-Pierre Bogaert CEO	Chief Executive Officer	-	1978-12-31
Timothy Foubert DFI	Director of Finance/CFO	-	-
Frank Zeuner CTO	Chief Tech/Sci/R&D Officer	-	-

More insiders

bonyf NV specializes in the development, manufacture and marketing of oral and wound care products. The activity is organized around 4 families of products: - oral care products: brushing products (PerioTabs brand) and mouth ulcer creams (AphtoFix); - denture care products: adhesive creams (OlivaFix brand), disinfecting denture tablets (NitrAdine), emergency denture repair systems for removable dentures (BonyPlus), effervescent denture cleanser tablets, etc.; - orthodontic care products: brushing solutions (PerioTabs brand) and disinfecting denture tablets for removable appliances (NitrAdine); - wound care products: paste dressings to fill cracks and fissures on feet (HeelFix brand) and hands (FingerFix).

Employees

Sector

More about the company

Quotes

Date	Price	Change
26-09-04	€2.480	0.00%
26-09-03	€2.480	0.00%
26-09-02	€2.480	0.00%
26-09-01	€2.480	0.00%
26-08-31	€2.480	0.00%

Real-time Euronext Paris

More quotes

02-25	Paris-listed bonyf Withdraws Nasdaq Listing Plans, In Talks for China Partnerships	MT
25-10-15	Bonyf NV Receives the EU-MDR Certification Class IIa for PerioCream	CI
25-09-15	Bonyf NV Showcases Innovative Product Portfolio At Expopharm 2025 in Dusseldorf	CI
25-09-05	Bonyf Drops Plan for Capital Increase Amid 'Significant, Positive' Business Developments	MT
25-08-11	Bonyf NV Prepares to Launch Periocream	CI
25-06-02	Group Pharmaceuticals Limited acquired an additional minority stake in bonyf N.V..	CI
25-05-15	Bonyf N.V. Announces First Exports to the United States with Honest Pharma	CI
25-04-08	Bonyf Moves to Late-stage Trial of Denture Adhesive Cream	MT
25-04-08	Bonyf NV Advances to Phase 3 in the Development of Alginate-Organic Denture Fixative Cream	CI
25-02-18	Belgium's Bonyf to Expand Presence via Dual Listing on Nasdaq Bourse	MT
23-03-16	177,284 Ordinary Shares of bonyf N.V. are subject to a Lock-Up Agreement Ending on 17-MAR-2023.	CI
22-09-16	236,379 Ordinary Shares of bonyf N.V. are subject to a Lock-Up Agreement Ending on 17-SEP-2022.	CI
22-06-15	Belgium-based bonyf Enters Contracts to Commercialize Dental Products in Malaysia, Philippines	MT

08-31	Bonyf : EN PR bonyf enters a new era of “Renaissance” driven by its own brands and the international launch of PerioCream	PU
07-20	Bonyf : Confirms Strategic Transformation and Long-Term Growth Vision	PU
05-20	Bonyf : Annual General Meeting Date and Business Update	PU
04-24	Bonyf : Update on General Shareholders’ Meeting and Periocream Launch in Italy	PU
02-25	Bonyf : provides strategic update on PerioCream® commercial expansion and Nasdaq listing plans	PU

3 months	-40.95%
6 months	-44.64%
Current year	-49.39%

1 week	2.48	2.48
1 month	2.48	2.48
Current year	2.48	5.25
1 year	2.48	12.9
3 years	2.48	19.5
5 years	2.48	19.5
10 years	2.48	19.5

bonyf NV Stock

Stocks

MLBON

BE6333353298

Chart: bonyf NV

Latest news : bonyf NV

Press Releases : bonyf NV

News in other languages : bonyf NV

Quotes and Performance

Price Extremes

Managers and Directors : bonyf NV

Company Profile

Quotes